Xcell Biosciences and ElevateBio Forge Partnership to Enhance Cell and Gene Therapy Development
Xcell Biosciences, Inc., a notable company in the field of cell and gene therapy applications, has recently unveiled a strategic …
All Posts
Life Sciences & Net Zero: Charting a Sustainable Path
Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. …
Enabling Pharma 4.0 Using AI: Interview With Rajiv Anand, Founder of Quartic.ai
Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …
Navigating the 2024 life science landscape: trends, challenges, and opportunities
As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside …
MIT Unveils Breakthrough Technique for Noninvasive RNA Expression Studies
Researchers at the Massachusetts Institute of Technology (MIT) have made significant advancement in the study of cellular processes such as cancer …
Arguably, the World's First Real-time Pathogen Detection Device
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in …
Isomorphic Labs Announces Collaborations with Eli Lilly and Novartis for AI-Driven Drug Discovery
Isomorphic Labs, a digital biology company specializing in AI applications, has entered into two distinct research collaborations with Eli Lilly …
7 Notable Companies Empowering Women’s Health with AI
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
Exploring a Novel Approach to Treat Primary Ciliary Dyskinesia: The RCT1100 Study
ReCode Therapeutics, a leader in genetic medicines, is pioneering a promising avenue in the treatment of primary ciliary dyskinesia (PCD) …
9 Notable AI Companies in Clinical Research to Watch in 2023
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Menarini Group and Insilico Medicine Forge Partnership for Novel Cancer Therapy Development
In a new development in oncology, the Menarini Group and Insilico Medicine have announced an exclusive global licensing agreement. This …
C4X Discovery: Advancing Drug Discovery with NRF2 Activator Program
C4X Discovery Holdings plc (AIM: C4XD), a drug discovery company, recently announced a significant milestone in its partnership with AstraZeneca. …